Introduction
The proper development of highly organized structures in the CNS is a complex process that determines appropriate connectivity in the adult. Neurotransmitters released during spontaneous and experience-driven synaptic activity play a crucial role in the formation of neuronal networks (Katz and Shatz, 1996; Zhang and Poo, 2001) . The most well documented example is glutamate, the major excitatory transmitter in the vertebrate CNS, which regulates nearly all aspects of neuronal network formation from migration to synaptogenesis (Zhang and Poo, 2001; Manent and Represa, 2007) . Recent advances have shown that GABA acts beyond its classical inhibitory role and also functions as an important developmental signal by regulating proliferation, migration, growth, and synapse formation (Ben-Ari et al., 2007) . With the observation that the activation of chloride-permeable GABA A receptors (GABA A -Rs) depolarizes developing neurons (Cherubini et al., 1991) , it was proposed that part of the trophic action of GABA relies on membrane depolarization and subsequent activation of voltage-dependent calcium channels (BenAri et al., 2007) . Consistent with this hypothesis, early conversion of GABA-induced depolarization into hyperpolarization impaired synapse formation and dendritic development of the target neurons both in vitro (Chudotvorova et al., 2005) and in vivo (Ge et al., 2006; Cancedda et al., 2007; Wang and Kriegstein, 2008; Reynolds et al., 2008) .
In addition to ionotropic GABA A -Rs, GABA also binds to metabotropic GABA B -Rs. These receptors are ubiquitously expressed at early stages of development, even before synapses are formed (Fritschy et al., 1999; Behar et al., 2001; Ló pez-Bendito et al., 2002 , and are activated by endogenous GABA released during early network-driven synaptic activity (McLean et al., 1996; Obrietan and Van den Pol, 1999; Catsicas and Mobbs, 2001; Ló pez-Bendito et al., 2003) . Although GABA B -R activity has been reported to modulate cortical neuronal migration (Behar et al., 1996 (Behar et al., , 2001 Ló pez-Bendito et al., 2003) , little attention has been paid to the possible contribution of GABA B -Rs in the functional development of neuronal networks.
In the present study, we tested the ability of CA3 hippocampal pyramidal cells to develop functional synaptic connections in the absence of functional GABA B -Rs. We found that activation of GABA B -Rs selectively promotes the development of hippocampal GABAergic synapses via the induction of brain-derived neurotrophic factor (BDNF) secretion. We further show that this process occurs during physiological patterns of synaptic activity. This study reveals a novel role of GABA B -Rs in regulating the self-refinement of GABAergic synaptic connections in the developing brain.
Materials and Methods
All animal experiments were carried out according to the guidelines laid down by the Inserm animal welfare committee and the European Communities Council Directive of 24 November 1986 (86/609/EEC).
Intact hippocampal formation and slice preparation. Experiments were performed on intact hippocampal formation (IHF) and hippocampal slices obtained from newborn [postnatal day 1 (P1) to P24] GABA B1 receptor subunit knock-out (GABA B1 -KO) and wild-type (GABA B1 -WT) mice (Prosser et al., 2001 ) and BDNF-KO and BDNF-WT mice (The Jackson Laboratory). The procedure for the preparation of the intact IHFs was similar to that previously described . Brains were removed from anesthetized (350 mg/kg chloral hydrate, i.p.) animals and immersed into ice-cold (2-4°C) artificial CSF (ACSF) of the following composition (in mM): 126 NaCl, 3.5 KCl, 2 CaCl 2 , 1.3 MgCl 2 , 1.2 NaH 2 PO 4 , 25 NaHCO 3 , and 11 glucose, pH 7.4, when equilibrated with 95% O 2 and 5% CO 2 . The hippocampi were then incubated for 12-16 h at 32°C in ACSF (oxygenated with 95% O 2 and 5% CO 2 ) alone or supplemented with different drugs. After the incubation, hippocampal slices (600 m thick) were cut with a McIlwain tissue chopper and kept in ACSF at 25°C for 60 min before use. Slices were then transferred to a submerged recording chamber and perfused with ACSF (3 ml/min) at 34°C. For each experiment, half of the dissected hippocampi were incubated in control conditions, and the other half incubated in treated conditions. Electrophysiological recordings on slices obtained from control and treated hippocampi were performed on the same day.
Electrophysiological recordings. Whole-cell patch-clamp recordings of CA3 pyramidal neurons were performed with an Axopatch 200B amplifier (Molecular Devices). To record miniature activity, borosilicate microelectrodes (4 -8 M⍀) were filled with the following solution (in mM): 110 CsCl, 30 potassium gluconate, 10 HEPES, 1.1 EGTA, 0.1 CaCl 2 , 4 MgATP, 0.3 NaGTP, 5-(and-6)-tetramethylrhodamine biocytin (rhodamine, 0.5-1%), pH ϭ 7.25, osmolarity ϭ 275 mosmol/L. Criteria for accepting a recording included a resting potential of ϽϪ55 mV, an R i of Ͼ400 M⍀, and an R s of Ͻ25 M⍀. Capacitance, input, and series resistances were measured online with Acquis Software (Biologic).
Miniature GABA A receptor-mediated postsynaptic currents (mGABA APSCs) were isolated in the presence of the ionotropic glutamatergic receptor antagonists [10 M 2,3-dihydroxy-6-nitro-7-sulfonyl-benzo [f]quinoxaline (NBQX), 40 M D-2-amino-5-phosphovaleric acid (D-APV)] and tetrodotoxin (1 M TTX) and recorded at a holding potential of Ϫ70 mV. Miniature glutamatergic postsynaptic currents were recorded in the presence of TTX (1 M) and the GABA A receptor antagonist bicuculline (10 M). Neurons were clamped at Ϫ70 mV. The currents were stored on an Axoscope 8.1 (Molecular Devices) and analyzed off-line with the Mini Analysis program (Synaptosoft 5.1). The fact that no false events would be identified was confirmed by visual inspection for each experiment. To generate the average PSCs, multiple overlapping events were discarded, and the remaining events were aligned on their rising phase. In the figures, the histograms were constructed using miniature PSCs recorded for 10 -30 min. To determine the probability of presence of giant depolarizing potentials (GDPs), an average of 13 Ϯ 6 cells (ranging from n ϭ 3 at P24 to n ϭ 23 at P1) were recorded in GABA B1 -WT slices and 14 Ϯ 7 cells (ranging from n ϭ 3 at P24 to n ϭ 27 at P2) in GABA B1 -KO slices.
Peak-scaled analysis of mGABA A -PSCs was performed as described by Traynelis et al. (1993) using Mini Analysis program (Synaptosoft 5.1). For each recording, we verified the absence of correlation between the decay time course and peak amplitude of mGABA A -PSCs. For each recording, we used between 50 and 200 events and eliminated all events with a decay time distorted by multiple peaks or anomalous noise. Each individual event was scaled to the peak of the mean waveform of the averaged event and subtracted. The mean variance was plotted against mean current. The plot was well fit by a parabolic function that yields the single-channel current i 0 and the number of channels contributing to mGABA A -PSCs, N 0 . From i 0 , the single-channel conductance ␥ can be calculated.
Paired-pulse relationship (PPR) of GABAergic synapses impinging onto CA3 pyramidal neurons was measured using pairs of identical stimuli at a 100 ms interval, delivered at a frequency of 0.01 Hz with a bipolar tungsten electrode placed in the CA3 stratum radiatum. The resulting pairs of postsynaptic GABA A currents (GABA A -PSCs) were isolated in the presence of 10 M CNQX, 40 M D-APV, and 5 M CGP55845. PPR was measured as the following amplitude ratio: second GABA A -PSCs/ first GABA A -PSCs. Average PPR values were calculated from 20 -30 paired stimulations.
Neuron reconstruction and morphometric analysis. Biocytin filling was done using the whole-cell patch-clamp technique. Briefly, after wholecell access, biocytin (1% in internal pipette solution) filling was done for 15 min. The slices were then fixed in PFA-PBS at 4°C overnight, and the biocytin-filled neurons were visualized using the avidin-biotin method. For 3-D reconstruction, a dendritic tree was digitized directly from the sections by use of a 20ϫ objective on a Nikon microscope, equipped with a motorized stage and coupled to a computer running Neurolucida software (Microbrightfield), thereby allowing for x-z coordinates of digitized points to be stored and analyzed.
Immunohistochemistry. Brains from P7 mice were fixed in 4% paraformaldehyde (overnight). Cryostat-cut hippocampal sections (30 m) were preincubated (1 h) in PBS-Triton X-100 (0.3%)-goat serum (3%) and then coincubated overnight at 4°C with antibodies to glutamic acid decarboxylase (Chemicon MAB351) and synaptophysin (Chemicon AB9272). Slices were washed with PBS, and Alexa Fluor 488 donkey antibody to mouse IgG (FluoProbes) and Cy3 donkey antibody to rabbit IgG (Chemicon) were applied (2 h). Sections were visualized with confocal microscopy (LSM 510, Zeiss). Five areas were sampled per animal, in the stratum radiatum and the stratum pyramidale. After the recording sessions, the optical sections were displayed in the form of digital images of 1024 ϫ 1024 pixels and processed using the ImageJ software (NIH, Bethesda, MD; http://rsb.info.nih.gov/ij/). All the pictures were reviewed to set a threshold to optimize the representation of puncta, and then the same threshold was applied to all images. The GAD65-labeled area fraction, defined as the percentage of GAD65-immunopositive pixels per field (1024 ϫ 1024 pixels), and the size of GAD65 puncta were measured. The proportion of colocalized immunoreactivity (IR) was expressed as the ratio: synaptophysin and GAD65 colocalized area/synaptophysin IR area or GAD65 IR area. For each section, counts were performed blindly in slices taken from three WT and three KO animals.
Cell cultures and transfections. Neurons from postnatal day 0 rat hippocampus were dissociated using trypsin and plated on coverslips coated with polyethylenimine as previously described (Kuczewski et al., 2008b) . Eleven days after plating, neurons were transfected with cDNAs coding for BDNF-GFP (gift from Dr. V. Lessmann, Institute of Physiology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany) according to the OZ Biosciences protocol (Buerli et al., 2007) . After transfection, the cultures were incubated at 30°C in 5% CO 2 . Immunostaining confirmed that BDNF-GFP is targeted to the dendrite and packed into secretory granules of the regulated pathway of secretion (Kuczewski et al., 2008b) .
Time-lapse imaging. Real-time imaging was performed as previously described (Kuczewski et al., 2008b) . Fluorescence intensity was measured from dendritic regions containing clusters of BDNF-GFP with ImageJ software after subtraction of background fluorescence. Clusters in which the fluorescence intensity varied during the 5 min control period by Ͼ5% were discarded from the analysis. Fluorescence decreases caused by photobleaching and constitutive release were corrected by subtracting the extrapolation of the fluorescence decrease in the first 5 min over the whole recording time. Values are plotted as the percentage of the fluorescence intensity of the last frame before stimulation. Percentage variation in the text and statistical analysis were calculated by comparing the relative fluorescence of the interval Ϫ100 to 0 s (control) with that of 400 -500 s (after stimuli).
Surface GFP immunofluorescence staining. The procedure for surface BDNF-GFP immunostaining was similar to that previously described (Kuczewski et al., 2008b) . Briefly, after being washed in ACSF, the living cultures were incubated at 4°C for 1 h in the presence of an anti-GFP antibody (10 g/ml; Molecular Probes). Cultures were then washed with 0.1 M PBS (4°C, pH 7.4) and fixed for 15 min with 4% paraformaldehyde-4% sucrose. After fixation, the neurons were exposed to a saturating concentration (10 g/ml) of either anti-rabbit secondary antibody coupled to Cy3 (FluoProbes) for 1.5 h under a nonpermeabilized condition. Quantifications were performed with ImageJ. Surface-bound BDNF-GFP on BDNF-GFP-expressing neurons was expressed as the following ratio: Cy3 and BDNF-GFP colocalized area/BDNF-GFP area.
Phospho-CREB activation and immunocytochemistry. The procedure for phospho-CREB activation and immunocytochemistry was similar to that previously described (Kuczewski et al., 2008b) . Briefly, 1 d before stimulation (at 13 DIV) one-half of the culture medium was changed to MEM with 2% B27 supplement. To reduce the basal level of CREB phosphorylation, cultures were incubated for 30 min in TTX (1 M). Five minutes before stimulation, NBQX (10 M), D-APV (40 M), and bicuculline (20 M) were added to medium. The cultures were then stimulated with baclofen (50 M) for 10 min in the absence or presence of TrkB-IgG (2 g/ml) or CGP55845 (10 M). Five to 10 min after stimulation, neurons were fixed for 15 min (4% paraformaldehyde) at 4°C and rinsed several times. Coverslips were then preincubated in PBSTriton-100 (0.1%)-goat serum (3%) for 1 h at room temperature and incubated overnight with mouse anti-CREB (1:1000) and rabbit antiphospho-CREB (pCREB, 1:1000) antibodies (Cell Signaling Technology). Immunoreactivities for pCREB and CREB were detected with an Alexa 488-coupled (A488) rabbit secondary antibody (1:500; FluoProbes) and a Cy3-coupled mouse secondary antibody (1:500; Jackson ImmunoResearch Laboratories), respectively. All procedures were performed in phosphate-free solution containing 140 mM NaCl, 5 mM KCl, and 10 mM HEPES-Na, pH 7.4. Images were acquired with an LSM 510 laser scanning confocal microscope (Zeiss). The acquisition of A488 (pCREB) and then Cy3 (CREB) was sequential to avoid overlap of excitation and emission of fluorescence. The optical sections were digitized (1024 ϫ 1024 pixels) and processed using ImageJ software. The pCREB-to-CREB intensity ratio was expressed as means value ratio of the pCREB-A488 staining intensity versus the CREBCy3 staining intensity.
ELISA. Brains of wild-type, GABA B1 -KO, and BDNF heterozygote mice were rapidly removed from their skulls at P6. Hippocampi were rapidly dissected out, weighed, and snap frozen in liquid nitrogen and stored at Ϫ80°C. BDNF was extracted from hippocampi by mechanical homogenization in a buffer containing 100 mM Tris-HCl, pH 7.0, containing 1 M NaCl, 4 mM EDTA, 2% Triton X-100, and the protease inhibitors 10 g/ml aprotinin, 10 g/ml leupeptin, and 17 g/ml PMSF. Homogenates were centrifuged at 14,000 ϫ g for 20 min. Supernatants were collected and analyzed with a commercial two-antibody sandwich ELISA (BDNF E max immunoassay system; Promega) according to the protocol of the manufacturer. The total protein content of each supernatant was measured with a Bradford protein assay. The BDNF level was expressed as the ratio of BDNF to the total soluble protein concentration. There was no significant difference in the weight of GABA B1 -WT and GABA B1 -KO hippocampi (9.87 Ϯ 0.31 mg/hippocampi vs 9.12 Ϯ 0.56 mg/hippocampi, respectively).
Drugs. NBQX, D-APV, bicuculline, and CGP55845 were purchased from Tocris Cookson. Tetrodotoxin and baclofen were purchased from Sigma. k252a was from Calbiochem. TrkB-IgG and TrkC-IgG were from R&D Systems.
Results

Miniature GABAergic synaptic activity is altered in mice lacking functional GABA B receptors
To address the contribution of GABA B -Rs to the development of the hippocampal circuit, we recorded miniature GABA A and glutamatergic-receptor-mediated postsynaptic currents (mGABA APSCs and mGlu-PSCs, respectively) from hippocampal CA3 pyramidal cells from P6 to P8 GABA B1 -KO mice, which display a complete loss of GABA B receptor function (Prosser et al., 2001 ). The frequency of mGABA A -PSCs was significantly reduced in GABA B1 -KO (0.73 Ϯ 0.12 Hz in GABA B1 -KO, n ϭ 13) when compared with their wild-type littermates (1.61 Ϯ 0.26 Hz, n ϭ 10, p ϭ 0.03) (Fig. 1 A, B) . This decrease in frequency was observed at all developmental stages studied (i.e., from P1 to P10) ( Fig. 1C; supplemental Fig. 1 , available at www.jneurosci.org as supplemental material). The mean amplitude, coefficient of variation of amplitude (CVa), and kinetic properties of mGABA A -PSCs were unchanged (Fig. 1 B; supplemental Fig. 1 , available at www.jneurosci.org as supplemental material). In contrast to mGABA A -PSCs, the average frequency of mGluPSCs was not different between GABA B1 -WT (0.11 Ϯ 0.017 Hz, n ϭ 10) and GABA B1 -KO (0.11 Ϯ 0.016 Hz, n ϭ 12) P6 -P8 neurons. The other parameters of mGlu-PSCs were also unchanged (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material). The membrane capacitance of the recorded cells, an indicator of neuronal size (Colin-Le ) (supplemental Fig. 3 , available at www.jneurosci.org as supplemental material), was not different between GABA B1 -WT and GABA B1 -KO (Fig. 1 B; supplemental Fig. 1 , available at www. jneurosci.org as supplemental material), suggesting that the morphological development of the target CA3 pyramidal cells was not affected. This observation was confirmed by quantitative morphometric analysis of intracellularly biocytin-loaded CA3 pyramidal neurons (Fig. 1 D-G) . Therefore, the development of GABAergic synapses is selectively impaired in mice lacking functional GABA B -Rs.
Blockade of GABA B -Rs in vitro mimics the deficit in GABAergic transmission observed in GABA B1 -KO mice In a previous study, we showed that the factors required for the functional maturation of GABAergic synapses in vivo are preserved in the IHFs in vitro (Colin-Le . We therefore used this preparation to overcome the potential pitfalls of genetic manipulations often observed in KO animals. IHFs obtained from P1 GABA B1 -WT mice were incubated at 32°C for 12-16 h in oxygenated control ACSF or with the GABA B -R antagonist CGP55845 (5 M). After the incubation period, hippocampal slices were prepared to record mGABA A -PSCs. In slices obtained from CGP55845-treated IHFs, the frequency of mGABA A -PSCs was significantly lower compared with control IHFs [0.107 Ϯ 0.024 Hz (n ϭ 11) vs 0.247 Ϯ 0.049 Hz (n ϭ 10), p ϭ 0.031] (Fig. 1 H) . The other mGABA A -PSC parameters were unchanged (supplemental Fig. 4a , available at www.jneurosci.org as supplemental material). P1 IHFs obtained from GABA B1 -KO mice were also incubated in control ACSF. The mean frequency of mGABA A -PSCs (0.117 Ϯ 0.026 Hz, n ϭ 8) was significantly lower compared with control GABA B1 -WT IHFs ( p ϭ 0.046) but similar to the value obtained in CGP55845-treated GABA B1 -WT IHFs (Fig. 1 H) . The other mGABA A -PSC parameters were unchanged (supplemental Fig. 4a , available at www.jneurosci.org as supplemental material). Therefore, the pharmacological blockade of the GABA B -Rs in vitro reproduces the deficit in GABAergic transmission observed in GABA B1 -KO mice, showing that it reflects the absence of GABA B -R activation by endogenous GABA.
Reduced perisomatic GABAergic synapses in mice lacking GABA B receptors
We next asked whether the deficit in GABAergic synaptic transmission resides in the presynaptic or the postsynaptic site. We first performed a peak-scaled variance analysis of mGABA APSCs which allows an estimate of the mean unitary conductance and the number of channels open at the peak of the synaptic current (Traynelis et al., 1993) and found no difference between GABA B1 -KO (n ϭ 6) and GABA B1 -WT (n ϭ 11) neurons (Fig.  2 A-C) . To detect possible changes in the probability of GABA release, we then measured the paired-pulse ratio and CVa of evoked GABA A -PSCs. We found no difference between GABA B1 -WT and GABA B1 -KO mice (n ϭ 5 for both) (Fig. 2 D-F ) . Finally, to investigate possible changes in the density of GABAergic terminals, we performed immunolabeling against GAD65, the synthetic enzyme for GABA. Double immunostaining against GAD65 and synaptophysin confirmed that GAD65 staining corresponds to GABAergic terminals (supplemental Fig. 5a -c, available at www.jneurosci.org as supplemental material). Quantitative analysis shows that, compared with the GABA B1 -WT hippocampi, the labeled area fraction was reduced by ϳ20% in the stratum pyramidale of GABA B1 -KO ( p ϭ 0.001), while the average size of GAD-positive puncta was unchanged (n ϭ 5 pairs of mice, 5 sections per mouse) (Fig. 2G-I ). There was, however, no difference in the labeled area fraction and average size of GAD65-positive puncta in the stratum radiatum of GABA B1 -KO and GABA B1 -WT hippocampi (Fig. 2G-I ) . Similar results were obtained with synaptophysin, a presynaptic marker (supplemental Fig. 5d ,e, available at www.jneurosci.org as supplemental material). Although functional presynaptic modifications cannot be completely excluded, together these data suggest that the deficit in GABAergic synaptic activity observed in GABA B1 -KO mice results at least in part from a decrease in the density of proximal GABAergic terminals.
GABA B -Rs are primarily activated by spontaneous network-driven synaptic activity We next asked whether and when GABA B -Rs are activated during ongoing synaptic activity. To address this point, we investigated the effect of the GABA B -R antagonist CGP55845 on GABA B1 -WT slices. We found that the duration of GDPs, the characteristic primitive network-driven pattern of synaptic activity (Ben-Ari et al., 1989) , was significantly increased in the presence of CGP55845 (5 M) (from 0.757 Ϯ 0.146 s to 1.738 Ϯ 0.617 s, n ϭ 8, p ϭ 0.0002) (Fig.  3A) . However, when applied in the presence of NBQX (10 M) and D-APV (40 M), to isolate spontaneous GABA A -PSCs, CGP55845 had no significant effect on the frequency, amplitude and charge transfer of sGABA A -PSCs in GABA B1 -WT neurons (n ϭ 9) (Fig. 3 B, C) . In agreement with previous findings that GABA B -Rs are activated by concomitant release of GABA from several interneurons (Scanziani, 2000) , these data show that the activation of GABA B -Rs by endogenous GABA required the presence of spontaneous GDPs.
The lack of GABA B -R activation is responsible for the deficit in GABAergic transmission
Network construction is modulated by the level and pattern of spontaneous synaptic activity generated in the developing ner- vous system. Thus, the deficit in GABAergic synaptic transmission observed in the GABA B1 -KO could be accounted for by alterations in spontaneous synaptic activity resulting from the lack of functional GABA B -Rs. We therefore characterized the spontaneous synaptic activity generated in the GABA B1 -KO. We found that GDPs were present in both GABA B1 -WT and GABA B1 -KO hippocampal slices from P1 to P10 and progressively disappeared by the end of the second postnatal week (Fig. 4 A, B) . No difference in timing of the disappearance of GDPs was observed between the two groups (Fig. 4 B) . There was also no difference in the frequency or amplitude of GDPs between GABA B1 -KO (n ϭ 33) and GABA B1 -WT (n ϭ 40) mice (Fig. 4C,D) . However, GDP duration was two-to threefold longer in GABA B1 -KO slices (1630 Ϯ 381 ms, n ϭ 40) compared with WT (740 Ϯ 97 ms, n ϭ 33, p ϭ 0.02) (Fig. 4 A, E) . The longer GDPs in GABA B1 -KO slices are networkdriven synaptic events because they were recorded with field electrodes and abolished by TTX (1 M) (data not shown). As expected, application of CGP55845 (5 M) had no effect on GDP duration in GABA B1 -KO slices (1555 Ϯ 72 ms in CGP55845, n ϭ 4). These data therefore show that GDPs are longer in GABA B1 -KO mice and that the lengthening of GDPs results from the lack of functional GABA B -R-mediated inhibition.
We next asked whether the deficit in GABAergic transmission observed in hippocampi deficient in GABA B -Rs is due to the lack of GABA B -R activity per se or is an indirect consequence of the lack of GABA B -R activity, i.e., the lengthening of GDP duration. To address this point, P1 WT IHFs were incubated for 12-16 h in the presence of TTX (1 M) to block action potential-dependent activity and GDPs. Since GABA B receptors are activated during GDPs, we hypothesized that blockade of GDPs with TTX treatment would reduce activation of GABA B -R and lead to a GABAergic deficit similar to that observed in GABA B -R-deficient hippocampi. We found that mGABA A -PSC frequency was indeed significantly reduced in TTX-treated IHFs (0.158 Ϯ 0.037 Hz, n ϭ 15) compared with control IHFs (0.270 Ϯ 0.036 Hz, n ϭ 15, p ϭ 0.045) (Fig. 4 F) . The other mGABA A -PSC parameters were unchanged (supplemental Fig.  4b , available at www.jneurosci.org as supplemental material). We next attempted to rescue the deficit induced by TTX with the specific GABA B -R agonist baclofen. Baclofen (5 M for 12-16 h) completely rescued the TTX-induced deficit [from 0.158 Ϯ 0.037 Hz (n ϭ 15) to 0.383 Ϯ 0.076 Hz (n ϭ 11), respectively, p ϭ 0.023] (Fig. 4 F; supplemental Fig. 4b , available at www. jneurosci.org as supplemental material). Finally, we investigated the consequences of treatment with baclofen alone, which also blocked GDPs while activating GABA B -Rs. We found that incubation with baclofen (5 M) had no significant effect on mGABA A -PSC frequency (0.390 Ϯ 0.082 Hz, n ϭ 11) when compared with control WT IHFs (Fig. 4 F; supplemental Fig. 4b , available at www.jneurosci.org as supplemental material). Together, these data show that the deficit in GABAergic synaptic transmission observed in GABA B -R-deficient IHFs is not a consequence of abnormal synaptic activity but rather results from the lack of GABA B -R activation during ongoing synaptic activity. 
GABA B -Rs and BDNF signaling interact to regulate the formation of functional GABAergic synapses
We next asked how activity-dependent activation of GABA B -Rs translates into functional development of GABAergic synapses. Considering that BDNF is a powerful modulator of GABAergic synapse development (Lessmann et al., 2003) , the recent observation that GABA B -R activity increases BDNF expression in cultured hippocampal neurons (Ghorbel et al., 2005 ) prompted us to test the possible contribution of BDNF-tropomyosin-related kinase (TrkB) receptor signaling to this synaptic development. P1 WT IHFs were incubated for 12-16 h with k252a (200 nM), a membrane-permeable inhibitor of protein tyrosine kinase. In k252a-treated IHFs, the frequency of mGABA A -PSCs was reduced compared with control IHFs [0.270 Ϯ 0.036 Hz (n ϭ 15) vs 0.105 Ϯ 0.028 Hz (n ϭ 14), p ϭ 0.002] (Fig. 5A) . The other mGABA A -PSC parameters were unchanged (supplemental Fig.  4c , available at www.jneurosci.org as supplemental material). The deficit induced by k252a was not rescued by baclofen [0.116 Ϯ 0.026 Hz k252a-treated IHFs (n ϭ 10) and 0.105 Ϯ 0.028 Hz (n ϭ 14) in k252a/baclofen-treated IHFs] ( Fig. 5A; supplemental Fig.  4c , available at www.jneurosci.org as supplemental material). Moreover, when incubated with k252a, the GABA B -R antagonist had no further effect on mGABA A -PSCs [0.088 Ϯ 0.024 Hz (n ϭ 11) in CGP55845/k252a-treated IHFs vs 0.105 Ϯ 0.028 Hz (n ϭ 14) in k252a-treated IHFs] ( Fig. 5A; supplemental Fig.  4c , available at www.jneurosci.org as supplemental material). These data show that GABA B -Rs promote the functional maturation of GABAergic synapses by means of a cascade involving tyrosine kinase signaling.
P1 WT IHFs were then incubated with the BDNF scavenger TrkB-IgG (1 g/ml) or with the NT3 scavenger TrkC-IgG (1 . An average of 13 Ϯ 6 cells (ranging from n ϭ 3 at P24 to n ϭ 23 at P1) were recorded in GABA B1 -WT slices, and 14 Ϯ 7 cells (ranging from n ϭ 3 at P24 to n ϭ 27 at P2) in GABA B1 -KO slices were also recorded to construct this graph. The Boltzmann fit shows that there is no significant difference in the disappearance of GDPs between GABA B1 -WT (dashed line) and GABA B1 -KO (dark line). C-E, Summary plot of GDP frequency (C), amplitude (D), and duration (E) in GABA B1 -WT (open bars) and GABA B1 -KO (filled bars). F, Left, Summary plot of the mGABA A -PSC frequency in recordings from GABA B1 -WT intact hippocampi incubated in vitro for 12-16 h in control condition (ACSF), in the presence of TTX (1 M) alone, TTX and baclofen (5 M), and baclofen alone. Right, Logarithmic plot of the mGABA A -PSC frequency in recordings from GABA B1 -WT and GABA B1 -KO intact hippocampi incubated in the corresponding conditions. Each symbol represents the result of one single cell. The dashed line represents the mean value obtained from GABA B1 -WT incubated in ACSF. baclo, Baclofen. g/ml). The frequency of mGABA A -PSCs was significantly reduced in TrkB-IgG-treated IHFs (0.105 Ϯ 0.033 Hz, n ϭ 8) compared with TrkC-IgG-treated IHFs (0.481 Ϯ 0.087 Hz, n ϭ 14, p ϭ 0.001) (Fig. 5B) . The other mGABA A -PSC parameters were not affected (supplemental Fig. 4d , available at www.jneurosci. org as supplemental material). The GABA B -R antagonist had no further effect on mGABA A -PSC frequency when incubated with TrkB-IgG (0.117 Ϯ 0.015 Hz, n ϭ 12) ( Fig. 5B; supplemental Fig.  4d , available at www.jneurosci.org as supplemental material) but significantly decreased the frequency of mGABA A -PSCs when incubated with TrkC-IgG (0.481 Ϯ 0.087 Hz, n ϭ 14, p ϭ 0.006 compared TrkC-IgG-treated IHF) ( Fig. 5B; supplemental Fig. 4d , available at www.jneurosci.org as supplemental material). These data show that endogenous GABA and BDNF, acting on GABA B -Rs and TrkB-Rs, respectively, interact to promote the functional maturation of hippocampal GABAergic synapses.
To confirm the requirement of GABA B -R and BDNF interaction for the functional maturation of GABAergic synapses, P1 IHFs obtained from BDNF-KO and WT littermates were incubated for 12-16 h in control ACSF or with CGP55845 (5 M). Incubation with the GABA B -R antagonist had no effect on the frequency of mGABA A -PSCs recorded from BDNF-KO IHFs (Fig. 5C ; supplemental Fig. 4f , available at www.jneurosci.org as supplemental material). Moreover, the frequency of mGABA A -PSCs from IHFs incubated in control ACSF was significantly reduced in BDNF-KO when compared with their wild-type littermates ( p ϭ 0.01) (Fig.  5C) , showing that BDNF is required for the functional maturation of hippocampal GABAergic synapses. Altogether, these data strengthen the conclusion that GABA B -Rs and BDNF interact to promote the maturation of GABAergic synapses in the developing mouse hippocampus.
To better determine the interplay between GABA B -Rs and BDNF-TrkB signaling, we attempted to rescue the deficit induced by CGP55845 with exogenous BDNF. P1 WT IHFs were incubated with CGP55845 (5 M) alone or with CGP55845 (5 M) and BDNF (50 ng/ml) for 12-16 h. BDNF rescued the deficit induced by CGP55845. The mGABA A -PSC frequency was 0.165 Ϯ 0.042 Hz in CGP55845-treated IHFs (n ϭ 21) and 0.331 Ϯ 0.069 Hz in CGP55845 and BDNF-treated IHFs (n ϭ 17, p ϭ 0.014) ( Fig. 5D ; supplemental Fig. 4e , available at www.jneurosci.org as supple- mental material). Incubation with BDNF (50 ng/ml) alone, however, had no significant effect on mGABA A -PSC frequency when compared with control WT IHFs [0.36 Ϯ 0.088 Hz in control IHFs (n ϭ 17) vs 0.407 Ϯ 0.038 Hz in BDNF-treated IHFs (n ϭ 14)] ( Fig. 5D; supplemental Fig. 4e , available at www.jneurosci. org as supplemental material). With the observation that baclofen failed to rescue the deficit in GABAergic synaptic activity induced by k252a (Fig. 5A) , these data show that GABA B -Rs promote the maturation of GABAergic synapses by controlling the amount of available extracellular BDNF.
Activation of GABA B -Rs triggers BDNF release
We next asked how GABA B -Rs control extracellular BDNF availability. GABA B -Rs could modulate the production and/or secretion of BDNF. To determine whether GABA B -Rs modulate BDNF production, we measured the level of BDNF in hippocampi of GABA B1 -KO and GABA B1 -WT by use of an ELISA and found no significant difference (110 Ϯ 7 pg/ml total protein vs 109 Ϯ 10 pg/ml total protein, respectively, n ϭ 5 for both).
In an attempt to determine whether GABA B -Rs could modulate the secretion of BDNF, we sought to measure the amount of BDNF released from mouse hippocampi in vitro upon GABA B -R activation using ELISA. However, levels of BDNF in these samples were below the threshold for detection of the assay. We therefore examined whether activation of GABA B -Rs triggers BDNF release at the cellular level. With this aim, we transfected cultured hippocampal neurons with GFP-tagged BDNF and monitored dendritic BDNF-GFP secretion with time-lapse fluorescent imaging in living neurons. Using this approach, BDNF-GFP secretion was detectable as a decrease in intracellular GFP fluorescence intensity (Kuczewski et al., 2008b) . To exclude indirect effects of synaptic activity, GABAergic and glutamatergic ionotropic receptor antagonists were present. Baclofen (10 M) led to a significant decrease of dendritic BDNF-GFP fluorescence intensity [Ϫ2.6 Ϯ 0.63% change 5 min after baclofen application, n ϭ 62 regions of interest (ROIs) from 14 cells, p ϭ 0.0008 compared with control period, p ϭ 0.01 compared with nonstimulated neurons, n ϭ 107 ROIs from 23 cells] (Fig. 6 A-C) . The decrease in fluorescence intensity induced by baclofen was prevented by CGP55845 (10 M, Ϫ0.74 Ϯ 0.53% change 5 min after baclofen application, n ϭ 42 ROIs from 11 cells, p ϭ 0.03 compared with baclofen alone) (Fig. 6 D) and by nominally Ca 2ϩ -free extracellular solution (0.005 Ϯ 0.005% change after 5 min of baclofen application, n ϭ 31 ROIs from 7 cells, p ϭ 0.0006 compared with baclofen alone) (Fig. 6 E) . The baclofen-induced secretion of BDNF-GFP was confirmed by surface-bound BDNF-GFP immunostaining (Kuczewski et al., 2008b) . Bath-applied baclofen (10 M, 10 min) increases GFP staining surrounding the BDNF-GFP-expressing cell (Fig. 6 F) . Quantification of surface-bound BDNF-GFP on transfected neurons shows that baclofen significantly increased BDNF-GFP release (n ϭ 10 cells for both, 3 cultures, p ϭ 0.04 compared with control) (Fig. 6G ). This effect was prevented by CGP55845 (10 M, n ϭ 11 cells, 3 cultures) (Fig. 6G) , which when applied alone had no effect on surfacebound BDNF-GFP in control conditions (n ϭ 5 cells, 3 cultures) (Fig. 6G) .
These data show that GABA B -R activation can trigger secretion of BDNF-GFP from hippocampal neurons in culture. However, protein overexpression could have modified the release properties of BDNF. To determine whether GABA B -R activation can trigger secretion of endogenous BDNF, we used the phosphorylated form of the cAMP response element-binding protein CREB (pCREB) as a sensor of endogenous BDNF release (Kuczewski et al., 2008b) . Once released, BDNF interacts with TrkB receptors to activate downstream signaling pathways. One of the most common is the ERK (extracellular signal-regulated kinase) pathway, which leads to the phosphorylation of CREB (Ghosh et al., 1994) . We therefore tested whether baclofen can induce a BDNF-dependent phosphorylation of CREB. Hippocampal neuronal cultures were stimulated with baclofen (3 and 50 M) for 10 min in the presence of NBQX (10 M), D-APV (50 M), and bicuculline (20 M). To rule out a possible effect of baclofen treatment on CREB synthesis and to normalize the results obtained from different cultures, the pCREB/CREB ratio was quantified (Fig. 7 A, B) . (Fig. 7B ). This increase was prevented by CGP55845 (10 M, n ϭ 43 cells; 3 cultures, p ϭ 0.0003 compared with baclofen) (Fig. 7B) , showing that GABA B -R activation is required. No difference in the pCREB/CREB ratio was observed when the cultures were stimulated by baclofen in the presence of the BDNF scavenger TrkB-IgG (2 g/ml, n ϭ 21 cells, 3 cultures, p ϭ 0.0002 compared with baclofen) (Fig. 7B) . As expected, BDNF (20 ng/ml) triggered a phosphorylation of CREB and an increase in the pCREB/CREB ratio (n ϭ 40 cells, 3 cultures, p ϭ 0.0001 compared with control) (Fig. 7B) . Thus, GABA B -R activation triggers secretion of endogenous BDNF.
Discussion
GABA, the main inhibitory transmitter in the adult vertebrate brain, has recently emerged as an important signal for neuronal development. Besides its classical role in regulating synaptic activity, GABA modulates nearly all key steps of network construction from neuronal migration to experience-dependent refinement of local connections (Ben-Ari et al., 2007) . Most of these effects have been attributed to the depolarizing action of GABA, which leads to a postsynaptic rise in intracellular Ca 2ϩ concentration in developing neurons via the activation of chloride-permeable GABA A -Rs (Ben-Ari et al., 2007) . Here, we reveal a novel mechanism by which endogenous GABA selectively regulates the development of GABAergic synapses. We found that activation of metabotropic GABA B -Rs triggers secretion of BDNF and promotes the development of GABAergic synapses in the hippocampus of newborn mice. Moreover, we show that this process occurs during ongoing physiological patterns of activity.
Our study shows that GABA B -R signaling plays a role in selfregulating inhibitory synapse development. We have identified a selective deficit in miniature GABAergic synaptic activity in GABA B1 -KO hippocampal pyramidal cells that can be reproduced in vitro in wild-type hippocampi in which GABA B -Rs were pharmacologically blocked. Miniature GABAergic activity was also reduced in wild-type hippocampi incubated with TTX, to block action potential-dependent synaptic activity and subsequent activation of GABA B -Rs. The TTX-induced deficit was rescued by the selective GABA B receptor agonist, baclofen, showing that GABA B -R activation is required for the functional maturation of GABAergic synapses. Although we cannot completely rule out functional presynaptic modifications, we provide morphological data suggesting that the reduced GABAergic activity in GABA B1 -KO mice is at least in part due to a decrease in the number of perisomatic GABAergic terminals. This result is consistent with previous findings that synaptic activity (Chattopadhyaya et al., 2004) and endogenous GABA levels (Chattopadhyaya et al., 2007) regulate cortical basket cell axon branching and perisomatic synapse formation through the activation of GABA A and GABA B receptors. Since miniature activity has been proposed to originate from proximal Figure 7 . GABA B -R activation induces a BDNF-dependent phosphorylation of CREB in hippocampal neuronal cultures. A, Immunofluorescence signal of CREB (red, left panels) and phosphorylated CREB (pCREB, green, middle panels) in hippocampal neuronal cultures in control conditions (top panels) or treated with baclofen in the absence (middle panels) or presence (bottom panels) of TrkB-IgG. Merged images are shown on the right. Scale bar, 10 m. B, Average pCREB/CREB ratio in the different conditions. For each condition, three different sister cultures were used, and quantification was based on 7-18 cells per culture. baclo, Baclofen; CGP, CGP55845.
